Ceva study shows consumer confusion over function of anti-parasitics

Ceva has published the results of a recent consumer survey indicating that more needs to be done to educate pet owners on the workings of their animals' anti-parasitic therapies.

According to the report, more than 60 percent of dog and cat owners mistakenly believe their pets are being treated for ticks, despite the ectoparasiticide they are using making no such claim.

A similar proportion made the same mistake when it came to flea eggs and larvae, while for lungworm this proportion stood at around one-third. This could mean that many domestic animals are not being treated adequately for potential parasite infestations.

Rob McLintock, companion animal business unit manager at Ceva Animal Health, said: "There is clearly a lot of confusion amongst pet owners as to which anti-parasitic treatments should be used to provide comprehensive protection against ectoparasites and endoparasites, and how frequently pets should be treated."

The report also underlined the benefits of the Ceva Protection System for dogs, a simple two-step solution featuring Vectra 3D and Milbactor to provide comprehensive ectoparasite and endoparasite protection for dogs, via a single monthly topical treatment and flavoured tablet.

It also offers the fast-acting Vectra Felis flea protection product for cats and Acclaim treatment for home environments under the Ceva Protection System branding.